Avacta Therapeutics vs Cellply

Avacta Therapeutics logo

Avacta Therapeutics

Expanding the reach of highly potent cancer therapies with the pre|CISION® platform

48 employees · est. 2012 · London, United Kingdom

VS
Cellply logo

Cellply

Unravelling immune system function, one cell at a time

34 employees · est. 2013 · Bologna, Italy

Avacta Therapeutics is the older company (2012 vs 2013).

Side-by-Side Comparison

Avacta Therapeutics Cellply
Founded
2012 older 2013
Headquarters
London, United Kingdom Bologna, Italy
Employees
48 34
Industry
Biotechnology, Health Care, Pharmaceutical Biotechnology, Health Care
Funding Stage
Post-IPO Equity Not tracked yet
Total Funding
Not tracked yet $17.44M
Funding Rounds
Not tracked yet 7
Services
FAP-Activated Drug Development, Tumor-Specific Therapeutic Solutions, Research and Development in Oncology Not tracked yet
Target Customers
Cancer Patients, Healthcare Providers, Oncology Researchers Not tracked yet
Taxonomy
Cancer TherapiesPre|CISION® PlatformBiopharmaceutical Drug DevelopmentClinical DiagnosticsAnalytical ToolsAnimal Health +7 Life ScienceAnalytical ToolsCancer ImmunotherapiesCell TherapiesBiotherapeuticsR&D Acceleration +8
Website
avacta.com cellply.com
Avacta Therapeutics logo

About Avacta Therapeutics

Avacta Therapeutics is a clinical stage biotechnology company founded in 2012 in the United Kingdom. Their mission, encapsulated in the slogan "Expanding the reach of highly potent cancer therapies with the pre|CISION® platform," reflects their focus on enhancing the effectiveness of cancer treatmen...

Cellply logo

About Cellply

Cellply is a biotechnology startup based in Italy, founded in 2013. The company's slogan "Unravelling immune system function, one cell at a time" reflects its core mission. Cellply is focused on developing next-generation analytical tools for in-depth characterization of cancer immunotherapies, cell...

Also comparing in this category

Comparing more than these two?

Get Avacta Therapeutics, Cellply and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Avacta Therapeutics compare?

A PDF of Avacta Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Frequently Asked Questions

Avacta Therapeutics was founded in 2012, based in London, United Kingdom, with 48 employees. Avacta Therapeutics is a clinical stage biotechnology company founded in 2012 in the United Kingdom. Their mission, encapsulated in the slogan "Expanding the reach of highly potent cancer therapies wi. Cellply was founded in 2013, based in Bologna, Italy, with 34 employees. Cellply is a biotechnology startup based in Italy, founded in 2013. The company's slogan "Unravelling immune system function, one cell at a time" reflects its core mission. Cellply is focused on devel.
Avacta Therapeutics has raised no disclosed funding and Cellply $17.44M. Latest stage: Avacta Therapeutics Post-IPO Equity.
Both work in Biotechnology and Health Care and list analytical tools among their focus areas.

Compare Avacta Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Avacta Therapeutics on 2 Jun 2026, and Cellply on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes